Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients

Genetic heterogeneity of EGFR and KRAS mutations in primary tumor tissue from non-small cell lung cancer patients

Activated epidermal growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations characterize molecular subgroups of non-small cell lung cancer (NSCLC) and have a strong predictive value for response to EGFR inhibitor therapy. Recently, EGFR mutation testing was incl...

Full description

Bibliographic Details
Main Author: Mattsson, Johanna
Format: Others
Language:English
Published: Uppsala universitet, Institutionen för medicinsk biokemi och mikrobiologi 2011
Subjects:
Non-small cell lung cancer
KRAS
EGFR
heterogeneity
mutation
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Internet

http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-159359

Similar Items